focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,256.00
Bid: 12,256.00
Ask: 12,260.00
Change: 160.00 (1.32%)
Spread: 4.00 (0.033%)
Open: 12,150.00
High: 12,286.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 10-Britain reports first death with Omicron coronavirus variant

Mon, 13th Dec 2021 07:20

* First publicly confirmed death globally from Omicron

* 200,000 Omicron infections per day in UK -health minister

* Get a booster as two vaccines not enough, Britain says

* Omicron will be dominant variant in London in 48 hours
(Adds more detail from health secretary)

By Guy Faulconbridge and Michael Holden

LONDON, Dec 13 (Reuters) - At least one person has died in
the United Kingdom after contracting the Omicron coronavirus
variant, Prime Minister Boris Johnson said on Monday, the first
publicly confirmed death globally from the swiftly spreading
strain.

Since the first Omicron cases were detected on Nov. 27 in
Britain, Johnson has imposed tougher restrictions and on Sunday
cautioned that the variant could overcome the immune defences of
those inoculated with two shots of vaccines.

Britain gave no details on the death other than the person
had been diagnosed in hospital. It was not clear if the patient
had been vaccinated or had underlying health issues.

Deaths from Omicron may have occurred in other countries but
none has been publicly confirmed yet outside Britain.

"Sadly at least one patient has now been confirmed to have
died with Omicron," Johnson told reporters at a vaccination
centre in London.

"So I think the idea that this is somehow a milder version
of the virus - I think that's something we need to set (to) one
side - and just recognise the sheer pace at which it accelerates
through the population."

Health Secretary Sajid Javid said the variant now accounted
for 44% of infections in London and would be the dominant strain
in the capital within 48 hours. New Omicron infections are
estimated at 200,000 per day, Javid said.

Before the death was announced, Britain said 10 people had
been hospitalised with Omicron in various parts of England.
Their ages ranged from 18 to 85 years and most had received two
vaccination doses.

The UK Health Security Agency said Omicron - first detected
in South Africa, Botswana and Hong Kong in late November - can
overcome the immunity of those who have had two shots of
vaccines such as AstraZeneca or Pfizer-BioNTech
.

South Africa's health ministry said it was unable to say
with certainty if any of its COVID-19 deaths were caused by
Omicron as deaths were not broken down by variant.

The World Health Organization said on Sunday that while
preliminary findings from South Africa suggest Omicron may be
less severe than the Delta variant - currently dominant
worldwide, and all cases reported in the Europe region have been
mild or asymptomatic, it remains unclear to what extent Omicron
may be inherently less virulent.

NEW LOCKDOWNS?

Johnson, now grappling with a rebellion in his party over
measures to curb Omicron and an outcry over staff parties at his
Downing Street office during last year's lockdowns, said people
should rush to get booster vaccines to protect "our freedoms and
our way of life".

After COVID-19 was first detected in China in late 2019, he
faced criticism for initially resisting lockdown.

He has also been criticised for overseeing mistakes in
transferring patients into care homes, and for building a costly
test-and-trace system that failed to stop a deadly second wave.

Johnson has repeatedly said that while mistakes were made,
the government was making decisions swiftly in the biggest
public health crisis for generations and that it was quick to
roll out vaccines.

More than 146,000 people have died from COVID-19 in the
United Kingdom.

Asked if he could rule out tougher restrictions in England
before Christmas, Johnson avoided giving a direct answer. His
health minister, Javid, said he knew of no plans for additional
measures. "There are no plans that I am aware of for any further
restrictions," Javid said.

VACCINE QUEUES

Johnson faces growing anger from libertarians in his party
over tougher curbs on daily life and sinking poll ratings.

He has also faced criticism over his handling of a sleaze
scandal, the awarding of lucrative COVID contracts, the
refurbishment of his Downing Street flat, and a claim that he
intervened to ensure pets were evacuated from Kabul during the
chaotic Western withdrawal from Afghanistan in August.

An Ipsos MORI poll for The London Evening Standard newspaper
showed opposition Labour leader Keir Starmer's ranking was 13
percentage points ahead of Johnson, the first time a Labour
chief was viewed as a more capable prime minister since 2008.

It also echoed other polls by showing Labour up three points
on 39% ahead of Johnson's Conservatives, who were down one point
since the last survey in November on 35%.

At St. Thomas' Hospital Vaccination Centre in central
London, a queue of hundreds of people snaked back onto
Westminster Bridge. Reuters journalists also documented queues
across London and in Manchester, northern England.

"The COVID vaccine booking service is currently facing
extremely high demand so is operating a queuing system," the
National Health Service said on Twitter. It suggested trying
again later.

Home testing kits were also unavailable to order.
(Reporting by Guy Faulconbridge and Michael Holden and Hannah
McKay; Editing by Angus MacSwan, Giles Elgood and Mark Heinrich)

More News
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.